Skip to main content
. Author manuscript; available in PMC: 2016 Apr 2.
Published in final edited form as: Adv Healthc Mater. 2014 Dec 22;4(5):760–770. doi: 10.1002/adhm.201400671

Figure 9.

Figure 9

Representative western blot analysis of NIH/3T3 cell extracts collected 48 h post-transfection (n = 4). Cells were treated with GAPDH targeted siRNA/mPEG-b-P(APNBMA)23.6 polyplexes with (+) or without (−) UV exposure (20 min), or with Lipofectamine lipoplexes containing either non-targeting or GAPDH targeting siRNAs.